![Michael Landsittel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Landsittel
Direktor/Vorstandsmitglied bei
DAMORA THERAPEUTICS, INC.
Profil
Derzeit hat Michael Landsittel die Position des Chief Financial Officer bei Blueprint Medicines Corp. inne. In seiner früheren Laufbahn hatte Herr Landsittel die Position des Finanzdirektors bei Infinity Pharmaceuticals, Inc. und des Senior Director-Finance bei Algeta US LLC inne. Herr Landsittel erhielt einen Undergraduate-Abschluss von der University of Michigan und einen MBA von der Tuck School of Business in Dartmouth.
Aktive Positionen von Michael Landsittel
| Unternehmen | Position | Beginn |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 23.03.2026 |
Ehemalige bekannte Positionen von Michael Landsittel
| Unternehmen | Position | Ende |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Finanzdirektor/CFO | 01.11.2025 |
Algeta US LLC
 Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Finanzdirektor/CFO | 01.07.2014 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2012 |
Ausbildung von Michael Landsittel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta US LLC
Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
